SCM
IART icon

Sio Capital Management’s Integra LifeSciences IART Stock Holding History

Sio Capital Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.61M Buy
+383,140
New +$4.21M 0.52% 46
2024
Q2 		– Sell
-137,000
Closed -$4.86M – 54
2024
Q1 		$4.86M Buy
+137,000
New +$5.48M 1.45% 27

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Sio Capital Management's IART Position: Q1 2026 in Review

Sio Capital Management opened a new position in Integra LifeSciences (IART) in Q1 2026: 383,140 shares worth $3.61M. The stake represents 0.52% of the portfolio and ranks #46 among its holdings. This is a return to the name: Sio Capital Management previously reported a position in IART as recently as Q1 2024.

Sio Capital Management first reported a position in IART in Q1 2024 and has held it in 2 quarters since. The position peaked at $4.86M in Q1 2024. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.

  • Sio Capital Management held 383,140 shares of Integra LifeSciences worth $3.61M as of Q1 2026.
  • Integra LifeSciences was a new Sio Capital Management position in Q1 2026.
  • Integra LifeSciences made up 0.52% of Sio Capital Management's portfolio in Q1 2026, its #46 holding.
  • Sio Capital Management first reported a position in Integra LifeSciences in Q1 2024 and has held it in 2 quarters since.
  • Sio Capital Management's Integra LifeSciences position peaked at $4.86M in Q1 2024.
  • 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on Sio Capital Management's 13F filing for Q1 2026, filed 14 May 2026.